Factors influencing antibody responses to acellular pertussis vaccines
Trollfors, B.
Developments in Biological Standardization 89: 279-282
1997
ISSN/ISBN: 0301-5149 PMID: 9272361 Document Number: 475863
There are several factors which can potentially affect the immune response of humans to vaccination with acellular pertussis vaccines. The only way to study these responses at present is by serology. Only for a few of these factors has the effect on humoral immunogenicity been studied in any way, making conclusions difficult. Nonetheless, at least gender and pre-existing, maternal antibody appear not to influence the serological response to acellular pertussis vaccination.
Document emailed within 1 workday
Related Documents
Rennels, M.B.; Reed, G.F.; Decker, M.D.; Edwards, K.M.; Pichichero, M.E.; Deloria, M.A.; Englund, J.A.; Anderson, E.L.; Steinhoff, M.C.; Deforest, A. 1995: Simultaneous administration of Haemophilus influenzae type b vaccine with acellular or whole-cell pertussis vaccine: effects on reactogenicity and immune responses to pertussis vaccines Pediatrics 96(3 Pt 2): 576-579Giuliano, M.; Mastrantonio, P.; Giammanco, A.; Bottone, M.; Piscitelli, A.; Di Tommaso, S.; Robino, L.; Basso, F.; D'Orazio, P. 1997: Antibody kinetics and long-term sero-prevalence in the Italian clinical trial of acellular pertussis vaccines Developments in Biological Standardization 89: 275-278
Granoff, D.M.; Rappuoli, R. 1997: Are serological responses to acellular pertussis antigens sufficient criteria to ensure that new combination vaccines are effective for prevention of disease? Developments in Biological Standardization 89: 379-389
Blumberg, D.A.; Pineda, E.; Cherry, J.D.; Caruso, A.; Scott, J.V. 1992: The agglutinin response to whole-cell and acellular pertussis vaccines is Bordetella pertussis--strain dependent American Journal of Diseases of Children 146(10): 1148-1150
Corbel, M. J. 1993: Developments in Biological Standardization, volume 73. Pertussis: Evaluation and Research on Acellular Pertussis Vaccines Journal of Medical Microbiology 38(2): 155-156
Corbel, M.J.; Xing, D.K. 1997: A consideration of control requirements for acellular pertussis vaccines Developments in Biological Standardization 89: 343-347
Storsaeter, J.; Gustafsson, L. 1997: Absolute efficacy of acellular pertussis vaccines in household settings Developments in Biological Standardization 89: 153-159
Noble, G.R.; Bernier, R.H.; Esber, E.C.; Hardegree, M.C.; Hinman, A.R.; Klein, D.; Saah, A.J. 1987: Acellular and whole-cell pertussis vaccines in Japan. Report of a visit by US scientists JAMA 257(10): 1351-1356
Rappuoli, R. 1996: Acellular pertussis vaccines: a turning point in infant and adolescent vaccination Infectious Agents and Disease 5(1): 21-28
Heijbel, H.; Rasmussen, F.; Olin, P. 1997: Safety evaluation of one whole-cell and three acellular pertussis vaccines in Stockholm trial II Developments in Biological Standardization 89: 99-100
Kallings, L.O.; Olin, P.; Storsaeter, J. 1988: Protective effect of 2 acellular pertussis vaccines in a double-blind placebo controlled clinical trial Lakartidningen 85(22): 1994-1996
Christy, C.; Pichichero, M.E.; Reed, G.F.; Decker, M.D.; Anderson, E.L.; Rennels, M.B.; Englund, J.A.; Edwards, K.M.; Steinhoff, M.C. 1995: Effect of gender, race, and parental education on immunogenicity and reported reactogenicity of acellular and whole-cell pertussis vaccines Pediatrics 96(3 Pt 2): 584-587
Dias, W.O.; Horton, D.S.; Takahashi, C.M.; Raw, I. 1994: A Bordetella pertussis acellular vaccine candidate: antigenic characterization and antibody induction Brazilian Journal of Medical and Biological Research 27(11): 2607-2611
Rastawicki, W.; Smietańska, K.; Rokosz-Chudziak, N.; Jagielski, M. 2013: Serum immunoglobulin IgG subclass distribution of antibody responses to pertussis toxin and filamentous hemagglutinin of Bordetella pertussis in patients with whooping cough Medycyna Doswiadczalna i Mikrobiologia 65(4): 269-274
Edwards, K.M.; Decker, M.D.; Halsey, N.A.; Koblin, B.A.; Townsend, T.; Auerbach, B.; Karzon, D.T. 1991: Differences in antibody response to whole-cell pertussis vaccines Pediatrics 88(5): 1019-1023
Isomura, S.; Suzuki, S.; Sato, Y. 1985: Clinical efficacy of the Japanese acellular pertussis vaccine after intrafamiliar exposure to pertussis patients Developments in Biological Standardization 61: 531-537
Cheng, H.Kock.; Rajadurai, V.S.; Amin, Z.; Sriram, B.; Yee, M.F.; Han, H.H.; Bock, H.L.; Safary, A. 2004: Immunogenicity and reactogenicity of two regimens of diphtheria-tetanus-acellular pertussis-hepatitis B-inactivated polio and Haemophilus influenzae type b vaccines administered to infants primed at birth with hepatitis B vaccine Southeast Asian Journal of Tropical Medicine and Public Health 35(3): 685-692
Edwards, K.M.; Lawrence, E.; Wright, P.F. 1986: Diphtheria, tetanus, and pertussis vaccine. A comparison of the immune response and adverse reactions to conventional and acellular pertussis components American Journal of Diseases of Children 140(9): 867-871
Chuprinina, R.P.; Alekseeva, I.A.; Ozeretskovskiĭ, N.A. 2006: Prophylaxis of pertussis: development and use of acellular pertussis vaccine Zhurnal Mikrobiologii Epidemiologii i Immunobiologii 2006(1): 99-105
Tiru, M.; Jäätmaa, E.; Gillenius, P.; Askelöf, P. 1985: Optimization of immunization schedule to standardize antibody response in mice to pertussis vaccines Developments in Biological Standardization 61: 469-475